Market
Which psychedelic will VA fund next by end of 2026?
3
Resolution / Starting Odds
Psilocybin • 25%
LSD • 25%
Ayahuasca • 25%
Other • 25%
Official VA announcements or research funding disclosures
Story
VA Funds $1.5 Million Study on MDMA-Assisted Therapy for Veterans with PTSD, First Psychedelic Research Since 1960s
Dec 5, 2024, 04:04 PM
The U.S. Department of Veterans Affairs (VA) has announced a historic initiative to fund a $1.5 million study on MDMA-assisted therapy aimed at treating post-traumatic stress disorder (PTSD) and alcohol use disorder among veterans. This marks the VA's first support for psychedelic research since the 1960s. Representatives Jack Bergman (R-MI) and Lou Correa (D-CA) have expressed their support for the initiative, highlighting its potential to address the veteran suicide crisis, which is reported to be 57% higher than that of civilians. The five-year study will be conducted by researchers from Brown University and Yale University. The decision to explore MDMA as a therapeutic option reflects a growing interest in psychedelics for mental health treatment, particularly in light of recent studies indicating their efficacy in reducing symptoms of PTSD and depression.
View original story
Similar markets
Same level of funding • 25%
Increased funding • 25%
No funding • 25%
Decreased funding • 25%
Roche • 25%
Novartis • 25%
Johnson & Johnson • 25%
Pfizer • 25%
Effective only for alcohol use disorder • 25%
Effective for both PTSD and alcohol use disorder • 25%
Not effective for either condition • 25%
Effective only for PTSD • 25%
Germany • 25%
Other • 25%
Spain • 25%
France • 25%
No • 50%
Yes • 50%
6-10 states • 25%
2 or fewer states • 25%
More than 10 states • 25%
3-5 states • 25%
United States • 25%
United Kingdom • 25%
Australia • 25%
Canada • 25%
Addiction • 25%
Depression • 25%
Anxiety • 25%
PTSD • 25%